MYL(600993) 每日经济新闻· Mei Ri Jing Ji Xin Wen·2025-04-15 11:33Core Insights - The article highlights the growing trend of pharmaceutical companies entering the beauty and skincare market, with notable examples such as Mayinglong and its 30% year-on-year revenue growth in its beauty product line for 2024 [1] - The competitive landscape is evolving, with some pharmaceutical brands successfully establishing themselves in the beauty sector, while others struggle to maintain profitability and market presence [2][3] Group 1: Pharmaceutical Companies Entering Beauty Market - Mayinglong reported a significant revenue increase in its beauty product line, indicating a successful cross-industry expansion [1] - Other pharmaceutical companies like Yunnan Baiyao and Pianzaihuang have also ventured into beauty, but face challenges such as market saturation and declining revenue in their beauty segments [5][6] - The trend of "dimensionality reduction" is noted, where pharmaceutical companies leverage their research and development strengths to compete in the beauty market [2][3] Group 2: Challenges and Market Dynamics - Many pharmaceutical companies are experiencing difficulties in the beauty market due to product homogeneity and a lack of innovative marketing strategies [6][7] - The shift towards scalp care products is emerging as a new opportunity, with companies like Yunnan Baiyao reporting significant revenue growth in this area [9] - The scalp care market is projected to grow, with pharmaceutical companies aiming to differentiate their products through unique formulations and proprietary ingredients [9]